GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Genovis GENO.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

21.00

-0.47%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

SEK 128.9m

FY2016FY2025

Net income

SEK 23.5m

FY2016FY2025

Free cash flow

SEK 30.4m

FY2016FY2025

Shareholders' equity

SEK 271.5m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueSEK 128.9mSEK 130.4mSEK 158.2mSEK 102.4mSEK 93.0mSEK 61.0mSEK 60.5mSEK 34.6mSEK 22.9mSEK 18.5m
Operating incomeSEK 27.5mSEK 45.7mSEK 54.2mSEK 8.6mSEK 24.5mSEK 6.9mSEK 13.5m−SEK 960,640−SEK 7.8m−SEK 14.8m
Net incomeSEK 23.5mSEK 32.9mSEK 61.5mSEK 11.2mSEK 24.8mSEK 6.4mSEK 9.6m−SEK 1.7m−SEK 7.9m−SEK 15.0m
Diluted earnings per share0.360.500.940.170.380.100.15-0.03-0.13-0.27

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 377.9mSEK 327.4mSEK 288.9mSEK 150.5mSEK 141.7mSEK 106.6mSEK 49.0mSEK 37.8mSEK 26.3mSEK 21.9m
Cash and short-term investmentsSEK 163.2mSEK 169.4mSEK 123.3mSEK 72.8mSEK 81.3mSEK 44.1mSEK 15.0mSEK 9.6mSEK 4.9mSEK 4.3m
Total liabilitiesSEK 106.4mSEK 99.4mSEK 98.0mSEK 24.9mSEK 27.8mSEK 19.5mSEK 13.4mSEK 11.8mSEK 8.1mSEK 6.3m
DebtSEK 73.1mSEK 76.6mSEK 79.3mSEK 7.3mSEK 2.8mSEK 6.7mSEK 4.7mSEK 2.2mSEK 351,500SEK 134,800
Shareholders' equitySEK 271.5mSEK 228.0mSEK 190.8mSEK 125.7mSEK 114.0mSEK 87.2mSEK 35.6mSEK 26.1mSEK 18.2mSEK 15.5m
Shares outstanding66m65m65m65m65m65m63m63m60m55m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsSEK 32.0mSEK 37.1mSEK 67.8m−SEK 927,947SEK 45.9mSEK 3.8mSEK 13.1m−SEK 1.2m−SEK 8.4m−SEK 16.1m
Capital spending−SEK 1.6m−SEK 1.1m−SEK 12.8m−SEK 3.8m−SEK 4.5m−SEK 20.4m−SEK 5.2m−SEK 1.8m−SEK 1.8m−SEK 1.4m
Free cash flowSEK 30.4mSEK 36.0mSEK 54.9m−SEK 4.8mSEK 41.4m−SEK 16.7mSEK 8.0m−SEK 3.1m−SEK 10.1m−SEK 17.5m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueSEK 34.3mSEK 33.5mSEK 40.3mSEK 27.5mSEK 28.9mSEK 32.3mSEK 27.9mSEK 32.9m
Operating incomeSEK 2.8mSEK 5.8mSEK 8.1mSEK 3.7mSEK 3.6mSEK 6.4mSEK 5.3mSEK 22.1m
Net incomeSEK 1.3mSEK 4.3mSEK 6.9mSEK 8.0mSEK 5.1mSEK 3.5mSEK 4.6mSEK 13.8m
Diluted earnings per share0.020.060.100.120.080.050.070.21
Cash from operationsSEK 7.0mSEK 16.0mSEK 15.0mSEK 10.0m−SEK 5.0mSEK 10.0mSEK 18.0m—
Capital spending−SEK 7.0m—−SEK 15.0m−SEK 10.0m−SEK 5.0m−SEK 10.0m−SEK 18.0m—
Free cash flowSEK 0—SEK 0SEK 0−SEK 10.0mSEK 0SEK 0—
Total assetsSEK 427.8mSEK 381.9mSEK 377.9mSEK 366.0mSEK 334.1mSEK 330.0mSEK 327.4mSEK 319.3m
Cash and short-term investmentsSEK 157.2mSEK 170.9mSEK 163.2mSEK 154.9mSEK 169.0mSEK 175.4mSEK 169.4mSEK 155.5m
DebtSEK 8.3mSEK 7.9mSEK 6.3mSEK 73.1mSEK 74.5mSEK 75.6mSEK 82.0mSEK 76.3m
Shareholders' equitySEK 308.0mSEK 277.4mSEK 271.5mSEK 263.5mSEK 238.8mSEK 232.6mSEK 228.0mSEK 222.2m

Financial ratios

Data as of 5 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin21.3%35.1%36.1%8.1%24.8%5.1%
Net margin18.2%25.3%38.9%10.9%26.6%10.6%
Return on equity8.7%14.4%32.2%8.9%21.7%7.4%
Return on assets6.2%10.1%21.3%7.4%17.5%6.0%
Free cash flow yield2.4%2.8%5.8%0.2%3.6%1.7%
Revenue growth-1.1%-17.6%54.5%10.1%52.4%0.8%
Earnings growth-28.6%-46.5%449.5%-54.8%284.4%-32.5%
Current ratio7.36x7.38x7.49x5.94x4.49x5.24x
Debt to equity0.02x0.02x0.02x0.02x0.01x0.08x
Equity ratio71.8%69.6%66.1%83.5%80.4%81.7%
Interest coverage7.29x11.56x25.23x24.49x7.03x3.17x
Buybacks as a share of market value-0.9%0.0%0.0%0.0%0.0%-3.7%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue8.0%16.1%25.5%
Operating income47.6%31.9%—
Net income28.1%29.5%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin28.2%26.2%24.8%16.7%
Net margin21.8%24.8%23.8%15.2%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings59.749.155.4268.8192.9319.9165.2-255.3-24.6-9.4
Price to sales10.912.421.529.451.433.826.112.68.57.6

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 10-to-1 reverse split · 4 Apr 2012

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.